Annual Total Liabilities
$20.07 M
-$3.14 M-13.51%
31 December 2023
Summary:
Viking Therapeutics annual total liabilities is currently $20.07 million, with the most recent change of -$3.14 million (-13.51%) on 31 December 2023. During the last 3 years, it has risen by +$7.91 million (+65.08%). VKTX annual total liabilities is now -20.26% below its all-time high of $25.17 million, reached on 31 December 2014.VKTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$26.44 M
+$581.00 K+2.25%
30 September 2024
Summary:
Viking Therapeutics quarterly total liabilities is currently $26.44 million, with the most recent change of +$581.00 thousand (+2.25%) on 30 September 2024. Over the past year, it has increased by +$12.02 million (+83.32%). VKTX quarterly total liabilities is now -21.37% below its all-time high of $33.63 million, reached on 31 March 2024.VKTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.5% | +83.3% |
| 3 y3 years | +65.1% | +132.9% |
| 5 y5 years | +340.0% | +298.8% |
VKTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.5% | +128.7% | -21.4% | +201.2% |
| 5 y | 5 years | -13.5% | +340.0% | -21.4% | +298.8% |
| alltime | all time | -20.3% | >+9999.0% | -21.4% | +3400.1% |
Viking Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $26.44 M(+2.2%) |
| June 2024 | - | $25.86 M(-23.1%) |
| Mar 2024 | - | $33.63 M(+67.5%) |
| Dec 2023 | $20.07 M(-13.5%) | $20.07 M(+39.2%) |
| Sept 2023 | - | $14.42 M(-1.1%) |
| June 2023 | - | $14.58 M(-13.4%) |
| Mar 2023 | - | $16.83 M(-27.5%) |
| Dec 2022 | $23.21 M(+164.4%) | $23.21 M(+50.7%) |
| Sept 2022 | - | $15.40 M(-5.4%) |
| June 2022 | - | $16.28 M(+27.6%) |
| Mar 2022 | - | $12.76 M(+45.3%) |
| Dec 2021 | $8.78 M(-27.8%) | $8.78 M(-22.7%) |
| Sept 2021 | - | $11.35 M(-11.8%) |
| June 2021 | - | $12.87 M(-0.3%) |
| Mar 2021 | - | $12.92 M(+6.2%) |
| Dec 2020 | $12.16 M(+70.4%) | $12.16 M(+23.7%) |
| Sept 2020 | - | $9.83 M(+6.3%) |
| June 2020 | - | $9.25 M(+4.9%) |
| Mar 2020 | - | $8.82 M(+23.6%) |
| Dec 2019 | $7.14 M | $7.14 M(+7.6%) |
| Sept 2019 | - | $6.63 M(+8.0%) |
| June 2019 | - | $6.14 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $5.51 M(+20.7%) |
| Dec 2018 | $4.56 M(-47.3%) | $4.56 M(-3.8%) |
| Sept 2018 | - | $4.74 M(+15.5%) |
| June 2018 | - | $4.11 M(-35.2%) |
| Mar 2018 | - | $6.34 M(-26.8%) |
| Dec 2017 | $8.66 M(+33.3%) | $8.66 M(-9.9%) |
| Sept 2017 | - | $9.61 M(+24.3%) |
| June 2017 | - | $7.73 M(+1.7%) |
| Mar 2017 | - | $7.61 M(+17.2%) |
| Dec 2016 | $6.49 M(-3.3%) | $6.49 M(+6.5%) |
| Sept 2016 | - | $6.10 M(+5.8%) |
| June 2016 | - | $5.76 M(-17.5%) |
| Mar 2016 | - | $6.99 M(+4.1%) |
| Dec 2015 | $6.71 M(-73.3%) | $6.71 M(+16.9%) |
| Sept 2015 | - | $5.74 M(+17.8%) |
| June 2015 | - | $4.88 M(-84.1%) |
| Mar 2015 | - | $30.61 M(+21.6%) |
| Dec 2014 | $25.17 M(+5740.3%) | $25.17 M(-0.4%) |
| June 2014 | - | $25.27 M(+3245.5%) |
| Mar 2014 | - | $755.40 K |
| Dec 2013 | $431.00 K(+308.9%) | - |
| Dec 2012 | $105.40 K | - |
FAQ
- What is Viking Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual total liabilities year-on-year change?
- What is Viking Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly total liabilities year-on-year change?
What is Viking Therapeutics annual total liabilities?
The current annual total liabilities of VKTX is $20.07 M
What is the all time high annual total liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total liabilities is $25.17 M
What is Viking Therapeutics annual total liabilities year-on-year change?
Over the past year, VKTX annual total liabilities has changed by -$3.14 M (-13.51%)
What is Viking Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VKTX is $26.44 M
What is the all time high quarterly total liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total liabilities is $33.63 M
What is Viking Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VKTX quarterly total liabilities has changed by +$12.02 M (+83.32%)